ライフサイエンスコーパス: syncopal

1 reduce but do not eliminate the risk of both syncopal and life-threatening cardiac events in adult pa

2 orthostasis but deteriorates in patients and syncopal control subjects immediately before and after V

3 t deteriorated significantly in patients and syncopal control subjects in the minutes before (P=0.027

4 tailed study of the pathophysiology of these syncopal disorders and more aggressive pursuit of carefu

5 Of these, 9 (20%) had experienced at least 1 syncopal episode before the fatal event.

6 owest risk was found in patients with only 1 syncopal episode occurring before the start of beta-bloc

7 While driving, 2 percent had a syncopal episode, 11 percent had dizziness or palpitatio

8 A 50-year-old white man with repeated syncopal episodes after exercise had a cardiac arrest an

9 Despite pacing, he had several syncopal episodes attributed to ventricular dysrhythmias

10 The number of syncopal episodes before therapy was 4.4 +/- 4.8.

11 y, for life-threatening events; those with 1 syncopal episodes in the last 2 years had an adjusted HR

12 , 7.0-19.5; P<.001) and those with 2 or more syncopal episodes in the last 2 years had an adjusted HR

13 ients were >/=40 years, had experienced >/=3 syncopal episodes in the previous 2 years.

14 2 months of follow-up or when a maximum of 3 syncopal episodes occurred within 1 month.

15 Multiple syncopal episodes occurring before initiation of beta-bl

16 First-time syncopal episodes usually occur in adults of working age

17 The mean number of previous syncopal episodes was 12 (range 9 to 20).

18 The median number of previous syncopal episodes was 6; asystolic response to tilt test

19 ients with >/=50% reduction in the number of syncopal episodes was 72% (95% confidence interval [CI]:

20 the mainstays of diagnosis and treatment for syncopal episodes, differentiation of syncope from life-

21 a structurally normal heart and unexplained syncopal episodes.

22 nital sensorineural deafness associated with syncopal episodes.

23 nt is congenitally deaf-mute, with recurrent syncopal events and a greatly prolonged QTc interval.

24 nder, QTc interval > or =500 ms, and interim syncopal events during follow-up after age 18 years were

25 Compared with those with no syncopal events in the last 10 years, patients with 1 or

26 follow-up period, but there were much fewer syncopal events than falls-28 episodes in paced patients

27 lcohol and, in particular, for understanding syncopal events that occur in association with alcohol i

28 Syncopal events were also reduced during the follow-up p

29 arily lead to the phobia because of repeated syncopal events.

30 Alcohol consumption may be linked to syncopal events.

31 ICD therapy are at very low risk for future syncopal ICD therapy.

32 Syncopal patients had similarly poor outcomes compared w

33 Syncopal patients presented with higher right atrial pre

34 Syncopal patients with a known or provisional diagnosis

35 In syncopal patients, the higher level of plasma epinephrin

36 es) and inappropriate shocks, mortality, and syncopal rate (secondary outcomes).

37 blood donation has some attendant risk, and syncopal reactions are more common among the youngest do

38 ive studies have been published on vasovagal syncopal reactions, antecubital nerve injuries (irritati

39 Even in untreated patients, the syncopal recurrence burden was low.

40 e no-pacemaker arm, the median time to first syncopal recurrence was 5 months, with a rate of 0.44 pe

41 efficacy of cardiac pacing for prevention of syncopal recurrences in patients with neurally mediated

42 to determine whether pacing therapy reduces syncopal recurrences in patients with severe asystolic n

43 ate hysteresis with no implant in respect to syncopal recurrences in patients with severe cardioinhib

44 e measured manually from standard ECGs in 10 syncopal rTOF patients (21.4 +/- 4.6 years after repair;

45 All patients had >2 syncopal spells and a Calgary Syncope Symptom Score >-3.

46 emale, median age 30 years) with a median 15 syncopal spells over a median of 9 years equally to flud

47 Syncopal subjects with carotid sinus syndrome were more

48 , 6-min walk distance, or etiology of PAH in syncopal versus nonsyncopal patients.

49 cardiac arrest, 17.0% (n=1399, 238 deaths); Syncopal VT, 21.2% (n=598, 127 deaths); Symptomatic VT,

50 as were the categories of VF cardiac arrest, Syncopal VT, and Symptomatic VT, below.